Pathogenesis, diagnosis, complications and treatment of non-alcoholic fatty liver disease
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 8, Pages 69-83
AbstractNumber of non-alcoholic fatty liver disease (NAFLD) cases is increasing over time due to alteration of food habit, increase incidence of metabolic syndrome, and lack of exercise. Liver biopsy is the test for diagnosis and staging of NAFLD, but nowadays several biochemical markers, scoring systems, and imaging studies are available to diagnose and stage NAFLD which is linked to end-stage liver disease, hepatocellular cancer, and elevated cardiovascular- and cancer-related morbidity and mortality. Therefore urgent diagnosis and management are required to avoid complications related to NAFLD. This study summarizes the latest evidence on the epidemiology, natural history, pathogenesis, diagnosis and management of NAFLD.
- Article View: 28
- PDF Download: 72